Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.

about

The status of cryptococcosis in Latin America.

P2860

Q54237824-0C811CFE-CECA-4D1B-99DD-E32C83242014

P2860

Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.

Item

http://www.wikidata.org/entity/Q40155503

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Fluconazole Non-susceptible Cr ...... otericin B in an AIDS Patient.

@en

type

Item

label

Fluconazole Non-susceptible Cr ...... otericin B in an AIDS Patient.

@en

prefLabel

Fluconazole Non-susceptible Cr ...... otericin B in an AIDS Patient.

@en

P1476

Fluconazole Non-susceptible Cr ...... otericin B in an AIDS Patient.

@en

P2093

Alda Soares Dos Santos Quaglio

http://www.w3.org/2001/XMLSchema#string

Cristiane Masetto de Gaitani

http://www.w3.org/2001/XMLSchema#string

Letícia Aparecida Schiave

http://www.w3.org/2001/XMLSchema#string

Roberto Martinez

http://www.w3.org/2001/XMLSchema#string

Rodrigo de Carvalho Santana

http://www.w3.org/2001/XMLSchema#string

P2860

Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study

Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates

Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment

Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.

P2888

s11046-017-0165-1

P31

scholarly article

P356

10.1007/S11046-017-0165-1

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28656554

http://www.w3.org/2001/XMLSchema#string

P921

cryptococcosis

Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.

about

P2860

P2860

Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P921